Epigenetic testing opens new doors for multiple myeloma treatment

FHS
October 7, 2024
11:28 pm

Multiple myeloma is a type of blood cancer that appears mainly after the age of sixty. Its incidence, therefore, increases with the aging of the population.

Study reveals complex role of polyploidy in cancer and treatment resistance

Polyploidy is a state where a cell contains more copies of the genetic material than the usual “diploid” cell, which contains two copies.

October 21, 2024

Rezilient Health Secures $10M to Expand CloudClinics

What You Should Know: – Rezilient Health, a St. Louis-based tech-enabled healthcare company, announced today that it has secured $10M in Series A funding led

October 3, 2024

UVA researchers take on antibiotic resistance crisis with $1.2 million grant

University of Virginia researchers are working to outrace two dangerous germs known for quickly developing resistance to new antibiotics – and the scientists’ efforts could

October 10, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.